Agitation In Alzheimer's Disease

Reasonable travel expenses such as travel by taxi, may be reimbursed.

Food may be provided during long study visits if needed.

About This clinical research study

With an ageing population, medications to help treat the symptoms of Alzheimer’s disease (AD) become more needed than ever.

Statistics show that around 80% of patients show signs of agitation and aggression with an increase in prevalence as the disease progresses. Here at MAC, we understand that the condition is incredibly difficult to deal with.

Reasonable travel expenses such as travel by taxi, may be reimbursed.

Food may be provided during long study visits if needed.

Clinics

Greater Manchester, South Staffordshire, South Yorkshire and West Yorkshire

Therapy Area

Alzheimer's Disease

Gender and Age

Males and Females aged 50 - 90

A full description of the study will be given at the visit before you decide to participate. At that time, you will also receive the full patient information sheet (PIS).

If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.

The study being run at MAC research sites in Greater Manchester (Manchester), South Staffordshire (Cannock), South Yorkshire (Tankersley) and West Yorkshire (Leeds) is a Phase III, 16-week study to assess a new medication that could help alleviate symptoms of agitation associated with AD.

Over the 16-week period, there’ll be a total of 9 visits to a clinic nearest to you and 2 phone calls from a study doctor. The medication itself is currently known as AVP-786.

By participating you may be helping to contribute to the development of a new therapy for agitation in AD that may help improve the quality of life for many people.

Reimbursement: Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.

Key Inclusion Criteria

Key Exclusion Criteria

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible patients will receive a health screen and study participation will be in collaboration with the patient’s treating physician.

ABOUT CLINICAL RESEARCH STUDIES

Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.

If the study is successful, it may be an important step towards developing a promising new treatment.


MAC Clinical Research is currently conducting a trial to test a new potential treatment for agitation in Alzheimer’s disease.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • Hidden
  • Hidden
  • (You can enter any supporting information here)
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email